STAT Plus: Glaxo’s ViiV Healthcare tussles with Kazakhstan over an AIDS drug
PATRICK BAZ/AFP/GETTY IMAGES
A ViiV spokeswoman says the company is having ongoing conversations, is considering a number of solutions, and has a flexible pricing approach.
Suscribirse a:
Enviar comentarios (Atom)
No hay comentarios:
Publicar un comentario